Athira Pharma, Inc. (ATHA) Tops Q1 EPS by 46c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.19), $0.46 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $51.43 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Greenlane Holdings Inc. (GNLN) reported Q2 result